
Read More
Hyderabad-based pharma penny stock under Rs 50: Company Reports 19% Revenue...
In Q2 FY26, revenue stood at Rs 113 crore compared to Rs 139.5 crore in Q2 FY25, marking a 19 per ce...

In Q2 FY26, revenue stood at Rs 113 crore compared to Rs 139.5 crore in Q2 FY25, marking a 19 per ce...

The shares of the company saw a spurt in volume by more than 14 times....

The stock is trading at its 52-week low....